3rd Quarter - Amendment

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$24,255
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN —
MICHAEL MAWBY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1318 (115th), H.R. 5965 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.